Inhibition of HMGB1 by siRNA 5 days post-stroke in vivo blocked the EPC response, reduced peri-infarct angiogenesis, and aggravated neurological deficits (Hayakawa et al., 2012). Here, HMGB1 is linked to stroke disorder.